Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Becton, Dickinson and Company

BDXNYSE
Healthcare
Medical - Instruments & Supplies
$184.34
$-1.05(-0.57%)
U.S. Market opens in 15h 52m

Becton, Dickinson and Company (BDX) Stock Overview

Explore Becton, Dickinson and Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap66.7B
P/E Ratio29.96
EPS (TTM)$6.11
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$163.64
3 Months$138.04
1 Year Target$159.94

BDX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Becton, Dickinson and Company (BDX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.30, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $159.94.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.96 and a market capitalization of 66.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.57%
5-Day Change
3.91%
1-Month Change
16.23%
3-Month Change
21.66%
6-Month Change
49.37%
Year-to-Date (YTD) Change
20.28%
1-Year Change
29.50%
3-Year Change
24.41%
5-Year Change
23.51%
All-Time (Max) Change
12789.86%

Contact Information

201 847 6800
1 Becton Drive, Franklin Lakes, NJ, 07417-1880

Company Facts

700,000 Employees
IPO DateFeb 21, 1973
CountryUS
Actively Trading

Frequently Asked Questions